Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(9 sites)

United States

Children's Hospital Los Angeles, Los Angeles, California

University of California San Francisco, San Francisco, California

Indiana University, Indianapolis, Indiana

Johns Hopkins, Baltimore, Maryland

Washington University, St Louis, Missouri

New York Medical College, Valhalla, New York

Nationwide Children's Hosptial, Columbus, Ohio

Children's Hospital of Pennsylvania, Philadelphia, Pennsylvania

Medical College of Wisconsin/Children's Hospital of Wisconsin, Milwaukee, Wisconsin